1 to 10 of 104 trials

• A Study in People With Abnormal Fat Levels in the Blood

  conditions:	Dyslipidemia
  interventions:	PPAR alpha ; placebo
  last updated:	2007 Jan 24
  status:	completed
  sponsor:	Eli Lilly and Company

   

• A Study in People With Mild Hypertension

  conditions:	Mild Hypertension
  interventions:	PPAR alpha ; Hydrochlorothiazide ; Placebo
  last updated:	2007 May 11
  status:	completed
  sponsor:	Eli Lilly and Company

   

• A Study in People With High Cholesterol

  conditions:	Hypercholesterolemia
  interventions:	PPAR alpha ; atorvastatin ; placebo
  last updated:	2007 Apr 4
  status:	completed
  sponsor:	Eli Lilly and Company

   

• Effect of a PPAR-Alpha Agonist on the Age Related Changes in Myocardial Metabolism and Mechanical Function

  conditions:	Cardiovascular Diseases
  interventions:	fenofibrate
  last updated:	2009 Feb 18
  status:	active, not recruiting
  sponsor:	National Institute on Aging (NIA)

   

• The Effect of a Peroxisome Proliferator-Activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

  conditions:	Hypertension
  interventions:	fenofibrate ; Placebo
  last updated:	2009 Mar 30
  status:	not yet recruiting
  sponsor:	Vanderbilt University

   

• PPAR-Gamma Agonists, Rheumatoid Arthritis and Cardiovascular Disease

  conditions:	Rheumatoid Arthritis
  interventions:	pioglitazone
  last updated:	2007 Nov 6
  status:	recruiting
  sponsor:	University of Michigan

   

• Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic Patients

  conditions:	Diabetes Mellitus, Type 2
  interventions:	rosiglitazone(drug), blood pressure lowering effect
  last updated:	2006 Feb 9
  status:	completed
  sponsor:	Baskent University

   

• Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction

  conditions:	Diabetes Mellitus, Type 2
  interventions:	Rosiglitazone(drug), cardiac adverse effects
  last updated:	2006 Mar 9
  status:	completed
  sponsor:	Baskent University

   

• The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

  conditions:	Metabolic Syndrome
  interventions:	Pioglitazone ; Telmisartan
  last updated:	2009 Jun 23
  status:	completed
  sponsor:	Aligarh Muslim University

   

• Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

  conditions:	Head and Neck Cancer ; Precancerous/Nonmalignant Condition
  interventions:	pioglitazone hydrochloride
  last updated:	2009 Jan 24
  status:	active, not recruiting
  sponsor:	Masonic Cancer Center, University of Minnesota